IFRX Stock Analysis: Buy, Sell, or Hold?
IFRX - InflaRx N.V. Common Stock
$1.93
0.03 (1.58%)
▲
5d:
+19.14%
30d:
-21.86%
90d:
+99.4%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When IFRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IFRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IFRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IFRX is currently trading at $1.93, which is considered slightly low relative to its 30-day fair value range of $1.73 to $2.47.
Technical Outlook: Technically, IFRX is in a strong uptrend. Immediate support is located at $1.58, while resistance sits at $2.81.
Market Sentiment: IFRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.76 (+301.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IFRX is in a strong uptrend. Immediate support is located at $1.58, while resistance sits at $2.81.
Market Sentiment: IFRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.76 (+301.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.73 -
$2.47
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 301.8% below Wall St target ($7.76)
Trading Range Analysis
30-Day Trading Range
$1.73 -
$2.47
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.58
Resistance Level
$2.81
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.16
Wall Street Target
$7.76
(+301.8%)
Revenue Growth (YoY)
-80.8%
Share & Embed Analysis
Last updated: June 24, 2026 9:38 AM ET
Data refreshes hourly during market hours. Next update: 10:38 AM
Data refreshes hourly during market hours. Next update: 10:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IFRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 65 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 61 BUY |
